重复胎儿超声心动图在先天性心脏病中的临床效用
本研究回顾性分析了2012年至2019年间267例因结构性先天性心脏病接受多次胎儿超声心动图评估的病例,共534次随访检查。基于重复检查发现,15.4%的病例管理方案发生改变,40.4%的咨询内容发生改变;管理改变与初始诊断类型相关,肺动脉瓣异常/非 Critical 肺动脉狭窄、平衡型房室间隔缺损及左室流出道梗阻/主动脉瓣异常或主动脉缩窄/离断主动脉弓比例较高。结论认为随访胎儿超声心动图的临床效用与先心病类型相关,制定随访频率方案时应将先心病类型作为主要决定因素。
要点
- 重复胎儿超声心动图可改变部分先心病胎儿的管理和咨询,尤其见于流出道梗阻和平衡型房室间隔缺损。
- 孤立性室间隔缺损、动脉共干、肺静脉异常或孤立性主动脉弓侧别/分支异常者未见管理改变。
- 先心病类型是决定随访胎儿超声心动图频率的重要因素,但各类型最佳间隔尚需进一步研究。
诊断标准与关键数值
- 基于重复胎儿超声心动图的管理改变总体发生率为41/267(15.4%)。
- 管理改变与初始诊断显著相关(P < 0.001)。
- 初始诊断为肺动脉瓣异常/非 Critical 肺动脉狭窄者管理改变比例最高,为4/11(36.4%)。
- 平衡型房室间隔缺损管理改变比例为5/17(29.4%),左室流出道梗阻/主动脉瓣异常或主动脉缩窄/离断主动脉弓为19/68(27.9%)。
- 与室间隔缺损相比,平衡型房室间隔缺损(P = 0.025)和左心病变(P = 0.002)的管理改变显著更常见;右心病变呈管理改变增加趋势(P = 0.05)。
临床应用与阅片要点
- 对于初始诊断为流出道梗阻性病变或平衡型房室间隔缺损的胎儿,重复胎儿超声心动图可能影响分娩地点、分娩方式、房间隔造口计划、前列腺素输注等管理决策。
- 重复检查还可细化心脏诊断,从而改变预后判断和未来管理咨询。
- 孤立性室间隔缺损、动脉共干、肺静脉异常或孤立性主动脉弓侧别/分支异常者在本研究中未见管理改变,随访频率可酌情降低。
局限性
- 本研究为单中心回顾性研究,结论外推需谨慎。
- 原文指出需进一步研究以就各类型先心病的系列胎儿超声心动图检查频率达成共识。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To investigate the utility of repeat fetal echocardiography (FE) following a diagnosis of structural congenital heart disease (CHD) on the initial FE. We evaluated how often changes in management and counseling occurred based on subsequent FE findings and sought to determine which types of CHD were more likely to have changes in management and/or counseling based on repeat FE.
METHODS: This was a retrospective review of all patients who presented to our center between January 2012 and January 2019 and who had more than one FE performed for structural CHD. We reviewed consultation notes to determine whether management or counseling had changed based on FE findings at follow-up visits. Management variables included a change in location or mode of delivery, plan for atrial septostomy, initiation of prostaglandin infusion, umbilical line placement and planned admission location (nursery vs neonatal intensive care unit). We defined a counseling change as any of the above changes in management as well as any meaningful refinements in the cardiac diagnosis that led to a change in the overall prognosis or future management. Initial diagnoses were grouped into anatomically/hemodynamically relevant subgroups. Fisher's exact test was used to assess the relationship between the initial diagnosis and changes in management. Post-hoc pairwise comparisons were performed using Dunnett's test.
RESULTS: Between January 2012 and January 2019, 267 patients underwent 534 follow-up FE assessments performed for structural CHD. Management change based on repeat FE occurred in 41/267 (15.4%) cases. A change in management was associated with the diagnosis made at the initial visit (P < 0.001). The proportion of cases with a management change was highest among those with an initial diagnosis of pulmonary valve abnormality/non-critical pulmonary stenosis (4/11 (36.4%)), followed by balanced atrioventricular canal (AVC) defect (5/17 (29.4%)) and left ventricular outflow tract obstruction/aortic valve abnormality or coarctation/interrupted aortic arch (19/68 (27.9%)). No management change occurred in fetuses diagnosed with isolated ventricular septal defect (VSD), truncus arteriosus, pulmonary vein anomaly or isolated arch sidedness/branching abnormality. Compared to those with a VSD, management was significantly more likely to be changed in fetuses with a balanced AVC defect (P = 0.025) and left heart lesions (P = 0.002). Right heart lesions showed a trend towards an increased incidence of management change (P = 0.05). A counseling change based on repeat FE occurred in 108/267 (40.4%) cases. The proportion of cases with a counseling change was highest among those with an initial diagnosis of pulmonary valve abnormality/non-critical pulmonary stenosis (8/11 (72.7%)) and hypoplastic left heart syndrome/critical aortic stenosis (5/9 (55.6%)).
CONCLUSIONS: The clinical utility of follow-up FE is associated with the type of CHD diagnosed. Follow-up FE led to changes in management in several types of CHD, most commonly in cases with an initial diagnosis of right and left outflow obstructive lesions and balanced AVC defect. When developing programmatic protocols for the frequency of FE assessments, the type of CHD should be a major determinant, but additional studies are required to reach a consensus on how often serial FE should be performed for each type of CHD. © 2023 International Society of Ultrasound in Obstetrics and Gynecology.
引用
- Barris, Mikhno, Kornblit, et al. Clinical utility of repeat fetal echocardiography in congenital heart disease. Ultrasound Obstet Gynecol. 2023. PMID: 37128164. doi:10.1002/uog.26240
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。